Evidence map›Paper›PMID 33002544›Full record

ArticleDiabetes research and clinical practice2020

Diabetes and technology: A pilot study on the management of patients with insulin pumps during the COVID-19 pandemic.

Fabio Petrelli, Giovanni Cangelosi, Stefania Scuri, Paola Pantanetti, Francesca Lavorgna, Federica Faldetta, Cristina De Carolis, Renato Rocchi, Giulia Debernardi, Alexandra Florescu and 5 more

Abstract read
In one paragraph

Article in Diabetes research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Perspectives on Telemedicine during the Era of COVID-19; What Can Saudi Arabia Do?International journal of environmental research and public health · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fabio PetrelliSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.
Giovanni CangelosiAsur Marche, Area Vasta 4, Fermo, Italy.
Stefania ScuriSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.
Paola PantanettiAsur Marche, Area Vasta 4, Fermo, Italy.
Francesca LavorgnaAsur Marche, Area Vasta 4, Fermo, Italy.
Federica FaldettaAsur Marche, Area Vasta 4, Fermo, Italy.
Cristina De CarolisAsur Marche, Area Vasta 4, Fermo, Italy.
Renato RocchiAsur Marche, Area Vasta 4, Fermo, Italy.
Giulia DebernardiOspedale Maggiore Ausl Bologna, Italy.
Alexandra FlorescuAsur Marche, Area Vasta 4, Fermo, Italy.
Giulio NittariSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy. Electronic address: giulio.nittari@unicam.it.
Getu Gamo SagaroSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.
Giulia GardaSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.
Cuc Thi Thu NguyenDepartment of Pharmaceutical Administration and Economics, Hanoi University of Pharmacy, Hanoi, Viet Nam.
Iolanda GrappasonniSchool of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recent COVID-19 pandemic has accelerated the treatment process through IT/technological supports, useful in the management of chronic patients such as those affected by type 1 Diabetes Mellitus (T1DM). Specific routes for fragile patients such as those with micro-infusers have been created thanks to the application of "Diabetes Technology," which allows patients to monitor blood glucose quickly and easily. The present pilot study aimed to assess the quality of care provided to patients with micro-infusers in a delicate phase such as a pandemic lockdown. MATERIALS AND

methodsA mixed-methods approach was used. In the first part, with prior written consent, patients with insulin pumps enrolled voluntarily. In the second part, the focus group discussion (FGD) was carried out with the voluntarily enrolled participants. The FGD data were organized and analyzed by the thematic areas.

resultsThe number of patients with afferent insulin pumps at the center was 50 individuals. Among them, 20 patients voluntarily joined the first part of the study by completing the PACIC questionnaire, which gave an average result of 3.34 (min. 2.2 and max. 4.2). In the second part, the application of the focus group technique demonstrated that technology is decisive in the management of diabetic pathology, not only in the emergency phase.

conclusionsAt the time of public health crises, alternative strategies such as Tele-Nursing or Telemedicine could be crucial for the management of patients with micro-infuser not only in critical moments, such as lockdown, but also in ordinary health management.

Indexed as

TelemedicineAdultBlood GlucoseCOVID-19Diabetes Mellitus, Type 1Disease ManagementFemaleHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsMaleMonitoring, PhysiologicPilot ProjectsSARS-CoV-2Surveys and QuestionnairesBlood GlucoseHypoglycemic AgentsInsulinCOVID-19CSIIFocus groupT1DMTelemedicineTele-nursing

Identifiers

PMID33002544
PMCPMC8277429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.